Nurix Therapeutics, Inc. - Common Stock, par value $0.001 per share (NRIX)

CUSIP: 67080M103

Q4 2025 13F Holders as of 31 Dec 2025

Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
104,555,500
Total 13F shares
113,423,406
Share change
+26,553,310
Total reported value
$2,151,627,911
Put/Call ratio
36%
Price per share
$18.97
Number of holders
182
Value change
+$525,564,750
Number of buys
123
Number of sells
57

Quarterly Holders Quick Answers

What is CUSIP 67080M103?
CUSIP 67080M103 identifies NRIX - Nurix Therapeutics, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Nurix Therapeutics, Inc. - Common Stock, par value $0.001 per share (NRIX) as of Q4 2025

As of 31 Dec 2025, Nurix Therapeutics, Inc. - Common Stock, par value $0.001 per share (NRIX) was held by 182 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 113,423,406 shares. The largest 10 holders included BlackRock, Inc., Redmile Group, LLC, Deep Track Capital, LP, VANGUARD GROUP INC, GENERAL ATLANTIC, L.P., MORGAN STANLEY, Vestal Point Capital, LP, BAKER BROS. ADVISORS LP, FMR LLC, and STATE STREET CORP. This page lists 182 institutional shareholders reporting positions in this security for the Q4 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.